Full Text View
Tabular View
No Study Results Posted
Related Studies
Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)
This study is currently recruiting participants.
Study NCT00556686   Information provided by University of California, Davis
First Received: November 8, 2007   Last Updated: May 7, 2009   History of Changes

November 8, 2007
May 7, 2009
August 2006
December 2009   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00556686 on ClinicalTrials.gov Archive Site
 
 
 
Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)
Salivary Catecholamines in Aphthous Stomatitis

The purpose of this study is to examine how compounds produced in patients with canker sores affect wound healing.

The purpose of this study is to determine if salivary catecholamines are elevated in patients with the disease aphthous stomatitis. The results of this study will be combined with those performed in collaboration with a co-Investigator to understand the effects of catecholamines on mucosal wound healing and oral epithelial cell migration.

 
Observational
Case Control, Prospective
Canker Sore
 
  • Individuals with a history of canker sores.
  • Individuals with no history of canker sores.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
40
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 or older, both genders
  • History of recurrent aphthous ulcers with 4 or more episodes per year

Exclusion Criteria:

  • History of salivary gland disease including Sjogren's disease, parotitis, and sialolithiasis
  • History of benign or malignant salivary gland tumor
  • History of celiac disease, ulcerative colitis or Crohn's disease
  • Patients on medications that affect salivary flow such as anti-depressants and anti-cholinergic medications
Both
18 Years and older
Yes
Contact: Nasim Fazel, M.D., DDS 916-734-1438 nasim.fazel@ucdmc.ucdavis.edu
Contact: Jennifer Nava 916-734-1438 jennifer.nava@ucdmc.ucdavis.edu
United States
 
NCT00556686
Nasim Fazel, University of California Davis
200614581
University of California, Davis
 
Principal Investigator: Nasim Fazel, M.D., D.D.S. University of California, Davis
University of California, Davis
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP